Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States

Cancer

Volumn 123, Issue 1, 2017, Pages 81-89

  Yang, Ju Dong ^a   Altekruse, Sean F ^b   Nguyen, Mindie H ^c,d   Gores, Gregory J ^a   Roberts, Lewis R ^a  

^a MAYO CLINIC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Africa; age; early onset; liver cancer; Oceania

Indexed keywords

ADULT; AFRICA; ARTICLE; ASIA; CARIBBEAN ISLANDS; CENTRAL AFRICA; CENTRAL AMERICA; DISEASE SURVEILLANCE; EUROPE; FEMALE; HUMAN; IMMIGRANT; LIVER CELL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORTH AFRICA; NORTH AMERICA; ODDS RATIO; ONSET AGE; PACIFIC ISLANDS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX RATIO; SOUTH AFRICA; UNITED STATES; AGE; AGED; ANCESTRY GROUP; BIRTH; CANCER REGISTRY; CARCINOMA, HEPATOCELLULAR; ETHNIC GROUP; LIVER NEOPLASMS; MIDDLE AGED; PHYSIOLOGY; REGISTER; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AFRICA; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; PARTURITION; REGISTRIES; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84992051963     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30246     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–1491.
3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–538.
4. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol. 2014;109:542–553.
5. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7:448–458.
6. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991;350:429–431.
7. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
8. Sartorius K, Sartorius B, Aldous C, Govender PS, Madiba TE. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiol. 2015;39:284–290.
9. Yang JD, Gyedu A, Afihene MY, et al; Africa Network for Gastrointestinal and Liver Diseases. Hepatocellular carcinoma occurs at an earlier age in Africans, particularly in association with chronic hepatitis B. Am J Gastroenterol. 2015;110:1629–1631.
10. Fritz AP, Jack A, Shanmugaratnam K, Sobin L, Parkin DM. International Classification of Diseases for Oncology, third edition. Geneva: World Health Organization; 2000.
11. National Cancer Institute, National Institutes of Health. Surveillance, Epidemiology, and End Results (SEER) Program; National Cancer Institute. Overview of the SEER Program. Epidemiology and End Results. Bethesda, MD: National Cancer Institute, National Institutes of Health; 2015.
12. United Nations Population Division, Department of Economic and Social Affairs. World Population Prospects: The 2015 Revision. Classification of Countries by Major Area and Region of the World. New York: Population Division, United Nations; 2015.
13. Park JW, Chen M, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35:2155–2166.
14. Kirk GD, Lesi OA, Mendy M, et al. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology. 2004;39:211–219.
15. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer-Base No. 11. Lyon, France: International Agency for Research on Cancer; 2013.
16. Robbins HA, Engels EA, Pfeiffer RM, Shiels MS. Age at cancer diagnosis for blacks compared with whites in the United States. J Natl Cancer Inst. 2015;107(3).
17. US Census Bureau. Census 2000 Brief. Washington, DC: US Census Bureau; 2001.
18. US Census Bureau. Census 2000 Foreign-Born Profiles. Washington, DC: US Census Bureau; 2001.
19. Ladep NG, Lesi OA, Mark P, et al. Problem of hepatocellular carcinoma in West Africa. World J Hepatol. 2014;6:783–792.
20. Chen CJ, Wang LY, Lu SN, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology. 1996;24:38–42.
21. Unsal H, Yakicier C, Marcais C, et al. Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1994;91:822–826.
22. Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer. 1985;51:713–726.
23. Oyunsuren T, Kurbanov F, Tanaka Y, et al. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol. 2006;78:1688–1695.
24. Yan H, Yang Y, Zhang L, et al. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma. Hepatology. 2015;61:1821–1831.
25. de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015;62:1190–1200.